APPLICATION
ANDA077944
TYPE
ANDA
ORIGINAL APPROVAL
2006-07-19
LATEST ACTION
2024-11-21
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued
Products
MELOXICAMDiscontinued
MELOXICAM 7.5MG · TABLET · ORAL
MELOXICAMDiscontinued
MELOXICAM 15MG · TABLET · ORAL
Approval history
2024-11-21Labeling · Supplement 21 · standardAP
2022-01-07Labeling · Supplement 19 · standardAP
2016-10-04Labeling · Supplement 15 · standardAP
2016-10-04Labeling · Supplement 16 · standardAP
2015-07-01Labeling · Supplement 12 · standardAP
2011-01-28Labeling · Supplement 9AP
2010-09-30Labeling · Supplement 8AP
2008-10-27Labeling · Supplement 3AP
2007-03-29Labeling · Supplement 1AP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.